CMLFU
Income statement / Annual
Last year (2020), CM Life Sciences, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2020, CM Life Sciences, Inc.'s net income was -$192,244.00.
See CM Life Sciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2020
|
| Period Ended |
12/31/2020 |
| Operating Revenue |
$0.00 |
| Cost of Revenue |
$0.00
|
| Gross Profit |
$0.00
|
| Gross Profit Ratio |
0
|
| Research and Development Expenses |
$0.00
|
| General & Administrative Expenses |
$206,195.00
|
| Selling & Marketing Expenses |
$0.00
|
| Selling, General & Administrative Expenses |
$206,195.00
|
| Other Expenses |
$0.00
|
| Operating Expenses |
$206,195.00
|
| Cost And Expenses |
$206,195.00
|
| Interest Income |
$0.00
|
| Interest Expense |
$0.00
|
| Depreciation & Amortization |
$13,951.00
|
| EBITDA |
-$192,244.00 |
| EBITDA Ratio |
0
|
| Operating Income Ratio |
0
|
| Total Other Income/Expenses Net |
$13,951.00
|
| Income Before Tax |
-$192,244.00
|
| Income Before Tax Ratio |
0
|
| Income Tax Expense |
$0.00
|
| Net Income |
-$192,244.00
|
| Net Income Ratio |
0
|
| EPS |
-0.0035 |
| EPS Diluted |
-0.0035 |
| Weighted Average Shares Out |
$55.34 M
|
| Weighted Average Shares Out Diluted |
$55.34 M
|
| Link |
|
